ArticleJournal of translational medicine2025
Machine learning-driven prediction models and mechanistic insights into cardiovascular diseases: deciphering the environmental endocrine disruptors nexus.
Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Single-cell and machine learning reveal ROS-associated heterogeneity in hepatocellular carcinoma for precision medicine.BMC cancer · 2026Article
- Association of prognostic nutritional index with fecal incontinence and fecal incontinence severity index in individuals with osteoporosis: mediating roles of C-reactive protein and gamma-glutamyl transferase.Frontiers in nutrition · 2026Article
- IL6/IL10/TLR4 Govern Immunogenic Cell Death in Aortic Dissection.Cardiovascular therapeutics · 2026Article
- Associations of inflammation-related nutritional and metabolic status indices CAR and CTI with 90-day unfavorable functional outcomes in patients with acute ischemic stroke.Frontiers in nutrition · 2026Article
- Association of SPISE with prevalent and incident MASLD: a two-stage population-based study and development of a risk prediction model.Frontiers in nutrition · 2026Article
- Association Between Reproductive Lifespan and All-Cause and Cardiovascular Mortality in Women Aged 65 Years and Older: A Cohort Study Using NHANES 1999-2018 Data.International journal of women's health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiovascular disease (CVD) persists as the foremost cause of global mortality, yet the mechanistic links between environmental pollutants and CVD pathogenesis remain poorly defined. This study addresses this gap by integrating machine learning-driven epidemiology with computational biology to systematically evaluate the role of endocrine-disrupting chemicals (EDCs) in CVD development.
methodWe analyzed data from the NHANES cohort to identify CVD-associated EDCs using advanced predictive modeling. Molecular docking and dynamics simulations were employed to characterize interactions between prioritized compounds and the NOX2-p22phox complex, a key regulator of oxidative stress. Structural and functional impacts on NADPH oxidase activity were assessed through residue-level binding analysis and reactive oxygen species (ROS) quantification.
resultsMachine learning identified 3-hydroxyfluorene (3-HF) as a novel environmental risk factor for CVD. Molecular simulations revealed that 3-HF selectively binds to the transmembrane domain of the NOX2-p22phox complex, forming stable interactions with residues critical for structural integrity (e.g. T135, H160). These interactions destabilized the protein complex, impairing NADPH oxidase assembly and suppressing ROS generation. Further analysis demonstrated that 3-HF-mediated oxidative stress disruption correlates with vascular dysfunction pathways implicated in CVD progression.
conclusionThis study establishes 3-HF as a redox-disrupting environmental contaminant contributing to CVD through NOX2-p22phox targeting. By bridging population-level exposure data with atomic-scale mechanistic insights, our work provides a transformative framework for environmental health risk assessment and preventive intervention design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.